News

FDA Approves New Administration Method for Keytruda (pembrolizumab)

2025-09-22T11:46:06-05:00September 22nd, 2025|Hot Topics, News, Science and Research|

On September 19, 2025, the U.S. Food and Drug Administration (FDA) approved a new administration method for Keytruda (pembrolizumab). Under the new approval, Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) can now be given by subcutaneous injection, commonly known as a shot, [...]

GO2 for Lung Cancer and the Addario Lung Cancer Medical Institute Honor Karen Kelly, MD with the 2025 Bonnie J. Addario Lectureship Award 

2025-07-25T10:44:55-05:00July 25th, 2025|Hot Topics, News, Press Releases|

SAN CARLOS, CA – July 26, 2025 — GO2 for Lung Cancer (GO2) and the Addario Lung Cancer Medical Institute (ALCMI) are proud to announce that Karen Kelly, MD, chief executive officer of the International Association for the Study [...]

Go to Top